U.S. News

FDA to review J&J vaccine;

A Food and Drug Administration advisory committee is holding an all-day meeting meeting Friday to review the data on Johnson & Johnson’s candidate vaccine and is likely to give the vaccine a thumbs-up, leading to an expected FDA authorization for the shot in adults within the next few days. An FDA report released early Wednesday deemed it safe and effective.

Johnson & Johnson has agreed to provide 100 million doses of its vaccine in the U.S. by June, including 20 million by the end of March. Those doses will add to the 300 million doses Pfizer-BioNTech and Moderna each have promised to deliver by the end of July.

The vaccine was shown to be 72% effective in a U.S. trial in which all ethnic, racial and age groups benefited about the same, and was shown to be 85% effective in preventing the most severe disease .

Checkout latest world news below links :
World News || Latest News || U.S. News

Help us to become independent in PANDEMIC COVID-19. Contribute to diligent Authors.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button
SoundCloud To Mp3